Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Abstract

Zidovudine remains the mainstay in the treatment of patients infected with human immunodeficiency virus (HIV). The drug delays disease progression to acquired immunodeficiency syndrome (AIDS) and to AIDS-related complex (ARC), reduces opportunistic infections, and increases survival in patients with advanced HIV infection. There is evidence to suggest that… (More)
DOI: 10.2165/00003495-199346030-00010

Topics

Cite this paper

@article{Wilde1993ZidovudineAU, title={Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.}, author={Michelle I. Wilde and Heather D. Langtry}, journal={Drugs}, year={1993}, volume={46 3}, pages={515-578} }